The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Find out how regular aerobic exercise can help combat Alzheimer's disease at its biological roots. Learn about the influence ...
The geroscience hypothesis focuses on extending the healthy lifespan by targeting aging mechanisms. Recent advances in ...
Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...
STOCKHOLM, SE / ACCESSWIRE / January 21, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
An analysis involving around two million people has linked weight-loss drugs to improved heart health, fewer infections, a ...
The Washington State Patrol is asking the community to keep an eye out for a 68-year-old man who has dementia and doesn’t ...
A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...
A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...